key: cord-0690542-80k8tyje
authors: Shokri, Somayeh; Mahmoudvand, Shahab
title: The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
date: 2022-04-06
journal: Ann Hepatol
DOI: 10.1016/j.aohep.2022.100704
sha: 5453984136b86a741d74bc66113a8c48b7862dd3
doc_id: 690542
cord_uid: 80k8tyje

nan

In conclusion, HCV screening should be implemented among all patients with COVID-19 before prescribing corticosteroids, one of the treatments of choice for COVID-19 infection.

Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis

Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy

Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study

Impact of steroids on hepatitis C virus replication in vivo and in vitro

Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C